Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anh Do

Showing results (351-360 of 379) with videos related to

Pageof 38
Sort By:
Cell Reports. Medicine|September 20, 2023
A blood-based metabolomic signature predictive of risk for pancreatic cancerEhsan Irajizad, Ana Kenney, Tiffany Tang, et al.
Nature Medicine|February 1, 2002
Steps toward mapping the human vasculature by phage displayWadih Arap, Mikhail G Kolonin, Martin Trepel, et al.
Ebiomedicine|December 1, 2023
Modulating a prebiotic food source influences inflammation and immune-regulating gut microbes and metabolites: insights from the BE GONE trialXiaotao Zhang, Ehsan Irajizad, Kristi L Hoffman, et al.
Ebiomedicine|June 21, 2016
Tissue Effects in a Randomized Controlled Trial of Short-term Finasteride in Early Prostate CancerJeri Kim, John W Davis, Eric A Klein, et al.
Gut|April 23, 2025
Long-chain sulfatide enrichment is an actionable metabolic vulnerability in intraductal papillary mucinous neoplasm (IPMN)-associated pancreatic cancersYihui Chen, Riccardo Ballarò, Marta Sans, et al.
Cancer Letters|February 9, 2025
Elevated levels of circulating microbial-associated uremic toxins are associated with metastatic duodenopancreatic neuroendocrine tumors in patients with Multiple Endocrine Neoplasia Type 1Riccardo Ballarò, Amanda R Wasylishen, Carolina R C Pieterman, et al.
The Journal of Clinical Endocrinology and Metabolism|June 12, 2023
Blood-based Proteomic Signatures Associated With MEN1-related Duodenopancreatic Neuroendocrine Tumor ProgressionJohannes F Fahrmann, Amanda R Wasylishen, Carolina R C Pieterman, et al.
Cell|August 10, 2019
Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer OutcomesErick Riquelme, Yu Zhang, Liangliang Zhang, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|October 29, 2024
Efficacy and Tolerance of First-Line Afatinib in Elderly NSCLC Patients with EGFR Mutations in Vietnam: A Multicenter Real-World StudyTu Anh Do, Hoa Thi Thai Nguyen, Phuong Cam Pham, et al.
The Journal of Clinical Endocrinology and Metabolism|July 28, 2021
A Blood-based Polyamine Signature Associated With MEN1 Duodenopancreatic Neuroendocrine Tumor ProgressionJohannes F Fahrmann, Amanda R Wasylishen, Carolina R C Pieterman, et al.
Pageof 38

Showing results (351-360 of 379) with videos related to

Sort By:
Pageof 38
Cell Reports. Medicine|September 20, 2023
A blood-based metabolomic signature predictive of risk for pancreatic cancerEhsan Irajizad, Ana Kenney, Tiffany Tang, et al.
Nature Medicine|February 1, 2002
Steps toward mapping the human vasculature by phage displayWadih Arap, Mikhail G Kolonin, Martin Trepel, et al.
Ebiomedicine|December 1, 2023
Modulating a prebiotic food source influences inflammation and immune-regulating gut microbes and metabolites: insights from the BE GONE trialXiaotao Zhang, Ehsan Irajizad, Kristi L Hoffman, et al.
Ebiomedicine|June 21, 2016
Tissue Effects in a Randomized Controlled Trial of Short-term Finasteride in Early Prostate CancerJeri Kim, John W Davis, Eric A Klein, et al.
Gut|April 23, 2025
Long-chain sulfatide enrichment is an actionable metabolic vulnerability in intraductal papillary mucinous neoplasm (IPMN)-associated pancreatic cancersYihui Chen, Riccardo Ballarò, Marta Sans, et al.
Cancer Letters|February 9, 2025
Elevated levels of circulating microbial-associated uremic toxins are associated with metastatic duodenopancreatic neuroendocrine tumors in patients with Multiple Endocrine Neoplasia Type 1Riccardo Ballarò, Amanda R Wasylishen, Carolina R C Pieterman, et al.
The Journal of Clinical Endocrinology and Metabolism|June 12, 2023
Blood-based Proteomic Signatures Associated With MEN1-related Duodenopancreatic Neuroendocrine Tumor ProgressionJohannes F Fahrmann, Amanda R Wasylishen, Carolina R C Pieterman, et al.
Cell|August 10, 2019
Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer OutcomesErick Riquelme, Yu Zhang, Liangliang Zhang, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|October 29, 2024
Efficacy and Tolerance of First-Line Afatinib in Elderly NSCLC Patients with EGFR Mutations in Vietnam: A Multicenter Real-World StudyTu Anh Do, Hoa Thi Thai Nguyen, Phuong Cam Pham, et al.
The Journal of Clinical Endocrinology and Metabolism|July 28, 2021
A Blood-based Polyamine Signature Associated With MEN1 Duodenopancreatic Neuroendocrine Tumor ProgressionJohannes F Fahrmann, Amanda R Wasylishen, Carolina R C Pieterman, et al.
Pageof 38